Cargando…
Returning to basic principles to develop more effective treatments for central nervous system disorders
Development of new treatments for diseases of the central nervous system (CNS) is stalled. Of candidate drugs developed through costly preclinical research, 93% fail clinical trials. Hoped-for improvements in diagnosis or treatment from decades of positron emission tomography (PET) and functional ma...
Autor principal: | Wexler, Bruce E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9158240/ https://www.ncbi.nlm.nih.gov/pubmed/35172621 http://dx.doi.org/10.1177/15353702221078291 |
Ejemplares similares
-
The long term effects of chemotherapy on the central nervous system
por: Duffner, Patricia K
Publicado: (2006) -
How chemotherapy damages the central nervous system
por: Meyers, Christina A
Publicado: (2008) -
Astrocytes in the central nervous system and their functions in health and disease: A review
por: Gradisnik, Lidija, et al.
Publicado: (2023) -
Critical Roles of Deubiquitinating Enzymes in the Nervous System and Neurodegenerative Disorders
por: Das, Soumyadip, et al.
Publicado: (2020) -
Fighting the Monster: Applying the Host Damage Framework to Human Central Nervous System Infections
por: Panackal, Anil A., et al.
Publicado: (2016)